L1CAM and endometrioid adenocarcinoma: In another study including 86 endometrioid and 30 non-endometrioid carcinomas, when the previously proposed cutoff value of 10% was applied, 44% of the tumors were L1CAM positive (clone 14.10, dilution 1:500) but showed no association with distant metastasis [35].